Colecchia, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 8.244
NA - Nord America 8.184
EU - Europa 4.235
SA - Sud America 2.590
AF - Africa 208
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 9
Totale 23.559
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.022
CN - Cina 2.348
SG - Singapore 2.173
BR - Brasile 2.097
HK - Hong Kong 1.878
GB - Regno Unito 883
VN - Vietnam 870
IT - Italia 866
SE - Svezia 526
RU - Federazione Russa 410
FI - Finlandia 366
DE - Germania 261
PL - Polonia 231
AR - Argentina 209
BG - Bulgaria 204
ID - Indonesia 202
KR - Corea 175
EC - Ecuador 114
IN - India 88
JP - Giappone 86
NL - Olanda 84
AU - Australia 78
MX - Messico 74
BD - Bangladesh 65
FR - Francia 64
TR - Turchia 60
UA - Ucraina 58
ZA - Sudafrica 58
IE - Irlanda 50
CA - Canada 47
AT - Austria 45
CO - Colombia 41
IQ - Iraq 38
PY - Paraguay 38
PK - Pakistan 36
EG - Egitto 34
LT - Lituania 34
RO - Romania 34
UZ - Uzbekistan 33
ES - Italia 30
IR - Iran 30
MA - Marocco 29
CL - Cile 27
VE - Venezuela 26
TN - Tunisia 22
PE - Perù 20
KE - Kenya 19
MY - Malesia 17
TH - Thailandia 15
AZ - Azerbaigian 14
CZ - Repubblica Ceca 13
MK - Macedonia 12
PH - Filippine 12
UY - Uruguay 12
BE - Belgio 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
NP - Nepal 10
SC - Seychelles 10
BH - Bahrain 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
GH - Ghana 7
JM - Giamaica 7
LB - Libano 7
SA - Arabia Saudita 7
BO - Bolivia 6
CH - Svizzera 6
EU - Europa 6
GR - Grecia 6
PA - Panama 6
DZ - Algeria 5
HN - Honduras 5
NG - Nigeria 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
GE - Georgia 4
GT - Guatemala 4
PS - Palestinian Territory 4
PT - Portogallo 4
AM - Armenia 3
BW - Botswana 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
IL - Israele 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BY - Bielorussia 2
CG - Congo 2
GA - Gabon 2
LU - Lussemburgo 2
LV - Lettonia 2
Totale 23.517
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.878
Hong Kong 1.861
Singapore 1.246
Hefei 773
Fairfield 645
London 618
Ashburn 586
Nyköping 472
Beijing 341
Chandler 331
Ho Chi Minh City 330
Helsinki 328
Wilmington 260
São Paulo 247
Princeton 239
Woodbridge 231
San Diego 227
Warsaw 220
Los Angeles 217
Houston 211
New York 207
Sofia 204
Cambridge 203
Shanghai 174
Hanoi 173
Buffalo 170
Seoul 163
Seattle 160
The Dalles 155
Chicago 133
Jakarta 114
Milan 110
Modena 89
Moscow 89
Dallas 68
Melbourne 68
Bologna 67
Redondo Beach 67
Rio de Janeiro 67
Nuremberg 61
Southend 57
Salt Lake City 56
Ann Arbor 55
Rome 55
Tokyo 49
Belo Horizonte 47
Porto Alegre 47
Dublin 45
Kent 43
Munich 42
Elk Grove Village 41
Da Nang 39
Haiphong 39
Quito 38
Bremen 37
Jacksonville 37
Curitiba 36
Jersey City 36
Guangzhou 35
Guayaquil 35
Tashkent 31
Amsterdam 30
Council Bluffs 29
Johannesburg 29
Kilburn 29
Brasília 28
Frankfurt am Main 28
Biên Hòa 27
Norwalk 27
Tampa 27
Reggio Emilia 26
Orem 24
Campinas 23
Hải Dương 22
Phoenix 22
Dearborn 21
Vienna 21
Buenos Aires 20
Chennai 20
Lappeenranta 20
Mashhad 18
Nairobi 18
Salvador 18
Stockholm 18
Columbus 17
Atlanta 16
Manaus 16
Montreal 16
Ninh Bình 16
Ribeirão Preto 16
Thái Bình 16
Asunción 15
Brooklyn 15
Florence 15
Fortaleza 15
Goiânia 15
Parma 15
Santo André 15
Sorocaba 15
Ankara 14
Totale 15.495
Salva come PNG Salva come JPEG
Nome #
Gut Microbiota and Celiac Disease. 280
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 232
Adverse Food Reaction and Functional Gastrointestinal Disorders: Role of the Dietetic Approach 231
Incidence of gallstone disease in Italy: Results from a multicenter, population-based Italian study (the MICOL project) 221
Non-invasive methods can predict oesophageal varices in patients with biliary atresia after a Kasai procedure. 217
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. 216
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 198
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 179
Role of Vitamin D in Liver Disease and Complications of Advanced Chronic Liver Disease 174
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 173
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 173
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 172
"Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?" 168
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 166
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 166
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 165
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 163
A novel spleen-dedicated stiffness measurement by FibroScan® improves the screening of high-risk oesophageal varices 162
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 160
Transjugular Intrahepatic Portosystemic Shunt: Devices Evolution, Technical Tips and Future Perspectives 158
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 157
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 155
Growth and nutritional evaluation in children with chronic liver disease (CLD) before and after liver transplantation 152
A Combined Baveno VII and Spleen Stiffness Algorithm to Improve the Noninvasive Diagnosis of Clinically Significant Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease 151
Liver and spleen stiffness and other noninvasive methods to assess portal hypertension in cirrhotic patients: a review of the literature 147
Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis 146
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 144
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 142
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation 140
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma 139
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 138
Post COVID-19 irritable bowel syndrome 137
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 137
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 135
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 135
From Listing to Recovery: A Review of Nutritional Status Assessment and Management in Liver Transplant Patients 134
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 134
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 128
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 128
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods 128
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 127
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 127
DAAs treatment in hepatitis C virus recurrence after Liver Transplantation: clinical usefulness of non-invasive methods 126
Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition 124
Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome 123
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma 123
A new point-of-care portable immunosensor for non-invasive assessment of oro-ileal transit time by oral fluid tauroursodeoxycholate measurement after its oral load 123
The management of endoscopic retrograde cholangiopancreatography related infections risk: results of an italian survey at regional level 121
Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study 119
A RETROSPECTIVE STUDY ON INTRAHEPATIC CHOLESTASIS OF PREGNANCY: MARKERS OF PREMATURE DELIVERY 119
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 118
Creatine Supplementation to Improve Sarcopenia in Chronic Liver Disease: Facts and Perspectives 117
Gut microbiota and metabolic syndrome 117
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 117
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 117
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma 116
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 115
Liver fibrosis by FibroScan(®) independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 114
Hepatic steatosis in obese patients: clinical aspects and prognostic significance 114
Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease 113
Clinical manifestations of gallstone disease: evidence from the multicenter Italian study on cholelithiasis (MICOL) 113
Review article:the diagnosis of non-alcoholic fatty liver disease-availability and accuracy of non-invasive methods 113
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 113
Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease 111
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis 111
Unlocking the Power of Late-Evening Snacks: Practical Ready-to-Prescribe Chart Menu for Patients with Cirrhosis 109
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 109
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 107
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 106
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 104
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 104
Probiotics, Prebiotics and Other Dietary Supplements for Gut Microbiota Modulation in Celiac Disease Patients 104
A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study 102
Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance 102
Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension 102
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 101
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 101
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 101
Corrigendum to “Idiopathic pulmonary fibrosis and intestinal disorders: An observational study” [Ann Diagn Pathol 62 (2023) 152072] (Annals of Diagnostic Pathology (2023) 62, (S1092913422001745), (10.1016/j.anndiagpath.2022.152072)) 100
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 100
Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study 100
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 99
Dysbiosis in Celiac disease patients with persistent symptoms on gluten-free diet: a condition similar to that present in irritable bowel syndrome patients? 99
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon 99
Pancreatic ultrasound elastography and its clinical use in predicting the risk of pancreatic fistulas after pancreatic resection 99
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 98
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 98
Regolazione dei trasportatori placentari degli acidi biliari MRP2, MRP3, MRP4 da parte dell’acido ursodesossicolico in corso di colestasi gravidica 98
Gut microbiota and its pathophysiology in disease paradigms 97
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 96
Are noninvasive methods clinically useful in advanced, decompensated liver cirrhosis when "les Jeux Sont Faits"? 96
Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations 96
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: A systematic review and meta-analysis 95
Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study 95
Suppressing, stimulating and/or inhibiting: The evolving management of HCC patient after liver transplantation 94
Diverticular disease of the colon: new perspectives in symptom development and treatment 93
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness. 93
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference 93
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 92
Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon 90
Totale 13.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 158.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 158.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 21 16 28 76 27 60 12
2021/20222.566 35 27 12 8 34 29 743 185 338 48 754 353
2022/20231.813 307 184 151 85 162 208 46 249 211 30 87 93
2023/20242.351 30 91 133 139 469 157 129 220 364 140 130 349
2024/20257.601 141 33 55 540 1.415 1.030 683 358 1.029 447 611 1.259
2025/20268.765 956 761 1.916 2.725 1.323 1.084 0 0 0 0 0 0
Totale 23.870